Impact of Type 2 Diabetes Mellitus on the Prognosis of Non-Small Cell Lung Cancer
Open Access
- 31 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (1) , 321
Abstract
Objective: Type 2 diabetes mellitus (T2DM) is the most common metabolic disease and is characterized by sustained hyperglycemia. The impact of T2DM on the survival of lung cancer patients remains controversial. The aim of this study was to investigate the associations of type 2 diabetes with lung cancer mortality. Methods: From January 2019 to January 2020, 228 patients with non-small cell lung cancer (NSCLC) staging earlier than IIIA were included. Results: In our study, we found that the overall survival (OS) and progression-free survival (PFS) of lung cancer patients with diabetes was longer than non-diabetes group. Diagnosed T2DM was associated with the prognosis of lung cancer after adjusting for age and covariates. The association between T2DM and OS was influenced by age, stage of cancer and cancer treatment, as well as whether taking metformin was associated with the OS of lung cancer. However, with the adjustment for age and covariates, the relation trended to lose statistical significance. Conclusion: T2DM is an independent prognostic factor for patients with NSCLC staging before IIIA. The patients with both NSCLC and T2DM trended to having a longer OS, possibly due to metformin.Keywords
This publication has 33 references indexed in Scilit:
- Diabetes Mellitus and Risk of Bronchopleural Fistula After Pulmonary Resections: A Meta-AnalysisThe Annals of Thoracic Surgery, 2016
- Prevalence of type 2 diabetes mellitus among inland residents in China (2000–2014): A meta‐analysisJournal of Diabetes Investigation, 2016
- The Effect of Diabetes Mellitus on Lung Cancer PrognosisMedicine, 2016
- Metformin use and survival from lung cancer: A population-based cohort studyLung Cancer, 2016
- Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non–Small Cell Lung CancerClinical Cancer Research, 2015
- Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studiesBMJ, 2014
- Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancerMedical Oncology, 2013
- Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studiesEuropean Journal of Cancer, 2013
- Diabetes mellitus: A significant co‐morbidity in the setting of lung cancer?Thoracic Cancer, 2012
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010